Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:11 Issue:1 Number:3 ISSN#:2563-5476
RCT
ACE Report #13251
Ace Report Cover General Orthopaedics

Azithromycin Does Not Improve Survival or Clinical Outcomes in Hospitalized Patients with COVID-19


How to Cite

OrthoEvidence. Azithromycin Does Not Improve Survival or Clinical Outcomes in Hospitalized Patients with COVID-19. ACE Report. 2021;11(1):3. Available from: https://myorthoevidene.com/AceReport/Report/13251

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet. 2021 Feb 13;397(10274): 605-612.

Contributing Authors: RECOVERY Collaborative Group

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Of the 9433 patients participating in the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial, 7763 were randomized to receive azithromycin plus standard care (n=2582), or standard care alone (n=5181; 837 eventually crossed over to receive azithromycin or tocilizumab but were still included in the analysis). The primary outcome of interest was all-cause mortality at 28 days. Secondary outco...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE